This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.
A long-term partnership agreement to cure patients with Hepatitis C was signed between Etisalat Egypt, one of Egypt’s telecommunication companies, and the leading health and pharmacological marketing company Prime Pharma.
Etisalat Egypt will sponsor Prime Pharma’s Tour n’ Cure initiative, in collaboration with the Egyptian Tourism Authority to provide treatment for Hepatitis C patients from all around the globe. Etisalat Egypt said it aims through this partnership to support thousands of Egyptians who are awaiting treatment for Hepatitis C.
“We always aim to be a part of any event that contributes to alleviating the pain of Egyptians,” said Gamal El-Sadat, chairperson of Etisalat Egypt. “That is why we took this opportunity and participated in such an initiative.
Tour n’ Cure will receive medical tourists from across the globe, Etisalat Egypt’s CEO Hazem Metwally said. “Foreign patients will be tested and assigned treatment plans. That will be followed by a trip to one of the Egypt’s touristic cities where they can enjoy their vacation without being burdened by high treatment costs, as Hepatitis C treatment in Egypt costs a fraction of overseas treatments.”